110 related articles for article (PubMed ID: 25407966)
1. DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas.
Liao WH; Yang LF; Liu XY; Zhou GF; Jiang WZ; Hou BL; Sun LQ; Cao Y; Wang XY
BMC Cancer; 2014 Nov; 14():835. PubMed ID: 25407966
[TBL] [Abstract][Full Text] [Related]
2. The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies.
da Costa VG; Marques-Silva AC; Moreli ML
Syst Rev; 2015 Apr; 4():46. PubMed ID: 25927427
[TBL] [Abstract][Full Text] [Related]
3. Post cross-linked ROS-responsive poly(β-amino ester)-plasmid polyplex NPs for gene therapy of EBV-associated nasopharyngeal carcinoma.
Yuan C; Chang S; Zhang C; Dong D; Ding J; Mahdavian AR; Hu Z; Sun L; Tan S
J Mater Chem B; 2024 Mar; 12(12):3129-3143. PubMed ID: 38451208
[TBL] [Abstract][Full Text] [Related]
4. Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8.
Jiang Y; Yan B; Lai W; Shi Y; Xiao D; Jia J; Liu S; Li H; Lu J; Li Z; Chen L; Chen X; Sun L; Muegge K; Cao Y; Tao Y
Oncogene; 2015 Dec; 34(50):6079-91. PubMed ID: 25745994
[TBL] [Abstract][Full Text] [Related]
5. The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy.
Lo AK; Dawson CW; Lung HL; Wong KL; Young LS
Front Oncol; 2021; 11():640207. PubMed ID: 33718235
[TBL] [Abstract][Full Text] [Related]
6. Enhancive effect of N,N'-dinitrosopiperazine on inducing precancerous lesion on nasal and/or nasopharyngeal epithelia of TgN(p53mt-LMP1)/HT mice.
Tian DF; He YC; Lu FG; Tang FQ
J Zhejiang Univ Sci B; 2009 Mar; 10(3):172-9. PubMed ID: 19283871
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging assessment of residual tumor angiogenesis after insufficient microwave ablation and donafenib adjuvant therapy.
Ren Z; Feng G; Li B; Zhang C; Du Y
Sci Rep; 2024 Feb; 14(1):4557. PubMed ID: 38402352
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging parameter changes as an early biomarker of tumor responses following radiation therapy in patients with spinal metastases: a systematic review.
Mulyadi R; Putri PP; Handoko H; Zairinal RA; Prihartono J
Radiat Oncol J; 2023 Dec; 41(4):225-236. PubMed ID: 38185927
[TBL] [Abstract][Full Text] [Related]
9. CT and MRI findings of radiation-induced external auditory canal carcinoma in patients with nasopharyngeal carcinoma after radiotherapy.
Zhang X; Bai S; Li H; Hu H; Duan X; Chen M; Wang D; Chen Y; Zhang F; Shen J
Br J Radiol; 2015 Jun; 88(1050):20140791. PubMed ID: 25827205
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of radiation-induced sinusitis by MRI-based scoring system in nasopharyngeal carcinoma patients.
Zheng W; Yan T; Liu D; Chen G; Wen Y; Rao X; Wang Y; Zheng H; Yang J; Peng H
Radiat Oncol; 2023 Sep; 18(1):153. PubMed ID: 37723540
[TBL] [Abstract][Full Text] [Related]
11. Modulation Effects of the CEP128 Gene on Radiotherapy-Related Brain Injury: A Longitudinal Structural Study Using Multi-Parametric Brain MR Images.
Lin S; Lv X; Lin X; Chen S; Li Y; Xu M; Qiu Y; Tang L
J Magn Reson Imaging; 2024 Feb; 59(2):648-658. PubMed ID: 37249021
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of vascular normalization induced by recombinant human endostatin in nasopharyngeal carcinoma via dynamic contrast-enhanced ultrasonography.
Yang Z; Kang M; Zhu S; Huang J; Li X; Wang R
Onco Targets Ther; 2018; 11():7909-7917. PubMed ID: 30510431
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Angiogenesis and Pathological Classification of Extrahepatic Cholangiocarcinoma by Dynamic MR Imaging for E-Healthcare.
Tan J; Sun X; Wang S; Ma B; Chen Z; Shi Y; Zhang L; Shah MA
J Healthc Eng; 2021; 2021():8666498. PubMed ID: 34671450
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological Changes on Laryngeal Motor Neuropathways Cause Voice Disorders for Postradiotherapy Patients with Nasopharyngeal Carcinoma.
He C; Guo L; Zheng M; Peng H; Zhang X; Fan C; Zhao X; Gong P; Deng Z; Xu G; Chen C
J Voice; 2024 Apr; ():. PubMed ID: 38631941
[TBL] [Abstract][Full Text] [Related]
15. Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions.
Ma BB; Hui EP; Chan AT
Cancer Sci; 2008 Jul; 99(7):1311-8. PubMed ID: 18498420
[TBL] [Abstract][Full Text] [Related]
16. The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.
Türkbey B; Thomasson D; Pang Y; Bernardo M; Choyke PL
Diagn Interv Radiol; 2010 Sep; 16(3):186-92. PubMed ID: 19885783
[TBL] [Abstract][Full Text] [Related]
17. Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders.
Yip PL; You R; Chen MY; Chua MLK
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254872
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in nasopharyngeal carcinoma: insights, imaging, and therapeutic strategies.
Xia C; Zhao J; Huang Y; Miao H; Zhao F
Front Oncol; 2024; 14():1331064. PubMed ID: 38863627
[TBL] [Abstract][Full Text] [Related]
19. Effect of radiotherapy interruption on nasopharyngeal cancer.
Zhao F; Yang D; Li X
Front Oncol; 2023; 13():1114652. PubMed ID: 37091186
[TBL] [Abstract][Full Text] [Related]
20. Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect.
Siak PY; Heng WS; Teoh SSH; Lwin YY; Cheah SC
J Transl Med; 2023 Nov; 21(1):786. PubMed ID: 37932756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
